Cargando…
Role of MicroRNAs in Neuroendocrine Prostate Cancer
Therapy-induced neuroendocrine prostate cancer (t-NEPC/NEPC) is an aggressive variant of prostate cancer (PCa) that frequently emerges in castration-resistant prostate cancer (CRPC) under the selective pressure of androgen receptor (AR)-targeted therapies. This variant is extremely aggressive, metas...
Autores principales: | Sreekumar, Amritha, Saini, Sharanjot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029336/ https://www.ncbi.nlm.nih.gov/pubmed/35447888 http://dx.doi.org/10.3390/ncrna8020025 |
Ejemplares similares
-
Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer
por: Sreekumar, Amritha, et al.
Publicado: (2023) -
MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer
por: Akoto, Theresa, et al.
Publicado: (2020) -
Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010) -
MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016) -
MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020)